Obesity and excess protein and carbohydrate consumption are risk factors for thyroid cancer

Nutrition and Cancer

Volumn 64, Issue 8, 2012, Pages 1190-1195

  Marcello, Marjory Alana ^a   Sampaio, Aline Castaldi ^a   Geloneze, Bruno ^a   Vasques, Ana Carolina Junqueira ^a   Assumpção, Ligia Vera Montalli ^a   Ward, Laura Sterian ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CALORIC INTAKE; CANCER PATIENT; CANCER RISK; CANCER SUSCEPTIBILITY; CARBOHYDRATE INTAKE; CASE CONTROL STUDY; CONTROLLED STUDY; DIETARY FIBER; DIFFERENTIATED THYROID CANCER; DISEASE ASSOCIATION; ENERGY EXPENDITURE; ETHNICITY; FAT INTAKE; FEMALE; HUMAN; MACRONUTRIENT; MAJOR CLINICAL STUDY; MALE; OBESITY; PHYSICAL ACTIVITY; PROSPECTIVE STUDY; PROTEIN INTAKE; SMOKING; SOCIAL STATUS; STRUCTURED QUESTIONNAIRE; WORLD HEALTH ORGANIZATION;

ADULT; BODY MASS INDEX; CASE-CONTROL STUDIES; DIETARY CARBOHYDRATES; DIETARY FATS; DIETARY PROTEINS; ENERGY INTAKE; EXERCISE; FEMALE; HUMANS; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; PROSPECTIVE STUDIES; SEX FACTORS; THYROID NEOPLASMS;

EID: 84873629023     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2012.721154     Document Type: Article

References (58)

1. Wolin KY, Carson K, and Colditz GA: Obesity and cancer. Oncologist 15, 556-565, 2010.
2. Brindel P, Doyon F, Rachedi F, Boissin JL, Sebbag J, et al.: Anthropometric factors in differentiated thyroid cancer in French Polynesia: a case-control study. Cancer Causes Control 20, 581-590, 2009.
3. Engeland A, Tretli S, Akslen LA, and Bjorge T: Body size and thyroid cancer in twomillionNorwegian men andwomen. Br JCancer 95, 366-370, 2006.
4. Oh SW, Yoon YS, and Shin SA: Effects of excess weight on cancer incidences depending on cancer sites and histologic findings among men: Korea National Health Insurance Corporation Study. J Clin Oncol 23, 4742-4754, 2005.
5. Pirouzpanah S and Koohdani F: Nutritional facts about macronutrients in cancer. In: Bridging Cell Biology and Genetics to the Cancer Clinic: Transworld Research Network, (Ed.) Parvin Mehdipour, Transworld Research Network, Kerala, India. pp. 59-82, 2011.
6. Murtaugh MA, Herrick J, Sweeney C, Guiliano A, Baumgartner K, et al.: Macronutrient composition influence on breast cancer risk in Hispanic and non-Hispanic white women: the 4-Corners Breast Cancer Study. Nutr Cancer 63, 185-195, 2011.
7. Bourke L, Doll H, Crank H, Daley A, Rosario D, et al.: Lifestyle intervention in men with advanced prostate cancer receiving androgen suppression therapy: a feasibility study. Cancer Epidemiol Biomarkers Prev 20, 647-657, 2011.
8. Sun Z, Liu L, Wang PP, Roebothan B, Zhao J, et al.: Association of total energy intake and macronutrient consumption with colorectal cancer risk: results from a large population-based case-control study in Newfoundland and Labrador and Ontario, Canada. Nutr J 11 (18), 2012.
9. Franceschi S, Favero A, Decarli A, Negri E, La Vecchia C, et al.: Intake of macronutrients and risk of breast cancer. Lancet 347, 1351-1356, 1996.
10. Decarli A, Favero A, La Vecchia C, Russo A, Ferraroni M, et al.: Macronutrients, energy intake, and breast cancer risk: implications from different models. Epidemiology 8, 425-428, 1997.
11. Bidoli E, Talamini R, Bosetti C, Negri E, Maruzzi D, et al.: Macronutrients, fatty acids, cholesterol and prostate cancer risk. Ann Oncol 16, 152-157, 2005.
12. Wu JW, Cross AJ, Baris D, Ward MH, Karagas MR, et al.: Dietary intake of meat, fruits, vegetables, and selective micronutrients and risk of bladder cancer in the New England region of the United States. Br J Cancer 106, 1891-1898, 2012.
13. Romieu I, Lazcano-Ponce E, Sanchez-Zamorano LM, Willett W, and Hernandez-Avila M: Carbohydrates and the risk of breast cancer among Mexicanwomen. Cancer Epidemiol Biomarkers Prev 13, 1283-1289, 2004.
14. Allen NE, Appleby PN, Key TJ, Bueno-de-Mesquita HB, Ros MM, et al.: Macronutrient intake and risk of urothelial cell carcinoma in the european investigation into cancer and nutrition (EPIC). Epub, Int J Cancer 2012.
15. Rezzonico JN, Rezzonico M, Pusiol E, Pitoia F, and Niepomniszcze H: Increased prevalence of insulin resistance in patients with differentiated thyroid carcinoma. Metab Syndr Relat Disord 7, 375-380, 2009.
16. Rezzonico J, Rezzonico M, Pusiol E, Pitoia F, and Niepomniszcze H: Introducing the thyroid gland as another victim of the insulin resistance syndrome. Thyroid 18, 461-464, 2008.
17. Dal Maso L, La Vecchia C, Franceschi S, Preston-Martin S, Ron E, et al.: A pooled analysis of thyroid cancer studies: V. Anthropometric factors. Cancer Causes Control 11, 137-144, 2000.
18. Truong T, Baron-Dubourdieu D, Rougier Y, and Guenel P: Role of dietary iodine and cruciferous vegetables in thyroid cancer: a countrywide case-control study in New Caledonia. Cancer Causes Control 21, 1183-1192, 2010.
19. Kanno J, Onodera H, Furuta K, Maekawa A, Kasuga T, et al.: Tumorpromoting effects of both iodine deficiency and iodine excess in the rat thyroid. Toxicol Pathol 20, 226-235, 1992.
20. Yamashita H, Noguchi S, Murakami N, Kato R, Adachi M, et al.: Effects of dietary iodine on chemical induction of thyroid carcinoma. Acta Pathol Jpn 40, 705-712, 1990.
21. Kanno J, Matsuoka C, Furuta K, Onodera H, Miyajima H, et al.: Tumor promoting effect of goitrogens on the rat thyroid. Toxicol Pathol 18, 239-246, 1990.
22. Gaitan E: Goitrogens. Baillieres Clin Endocrinol Metab 2, 683-702, 1988.
23. Bosetti C, Negri E, Kolonel L, Ron E, Franceschi S, et al.: A pooled analysis of case-control studies of thyroid cancer: VII. Cruciferous and other vegetables (International). Cancer Causes Control 13, 765-775, 2002.
24. Kolonel LN, Hankin JH, Wilkens LR, Fukunaga FH, and Hinds MW: An epidemiologic study of thyroid cancer in Hawaii. Cancer Causes Control 1, 223-234, 1990.
25. Memon A, Darif M, Al-Saleh K, and Suresh A: Epidemiology of reproductive and hormonal factors in thyroid cancer: evidence from a case-control study in the Middle East. Int J Cancer 97, 82-89, 2002.
26. Memon A, Darif M, Al-Saleh K, and Suresh A: Epidemiology of reproductive and hormonal factors in thyroid cancer: evidence from a case-control study in the Middle East. Int J Cancer 97, 82-89, 2002.
27. Bufalo NE, Leite JL, Guilhen AC, Morari EC, Granja F, et al.: Smoking and susceptibility to thyroid cancer: an inverse association with CYP1A1 allelic variants. Endocr Relat Cancer 13, 1185-1193, 2006.
28. Granja F, Morari EC, Assumpcao LV, and Ward LS: GSTO polymorphism analysis in thyroid nodules suggest that GSTO1 variants do not influence the risk for malignancy. Eur J Cancer Prev 14, 277-280, 2005.
29. Granja F, Morari J, Morari EC, Correa LA, Assumpcao LV, Ward LS. GST profiling may be useful in the screening for thyroid nodule malignancy. Cancer Lett 209, 129-137, 2004.
30. Morari EC, Leite JL, Granja F, da Assumpcao LV, and Ward LS: The null genotype of glutathione s-transferaseM1 and T1 locus increases the risk for thyroid cancer. Cancer Epidemiol Biomarkers Prev 11, 1485-1488, 2002.
31. Granja F, Morari J, Morari EC, Correa LA, Assumpcao LV, et al.: Proline homozygosity in codon 72 of p53 is a factor of susceptibility for thyroid cancer. Cancer Lett 210, 151-157, 2004.
32. Xu L, Morari EC, Wei Q, Sturgis EM, and Ward LS: Functional variations in the ATM gene and susceptibility to differentiated thyroid carcinoma. J Clin Endocrinol Metab 97, 1913-1921, 2012.
33. Martins de Almeida JF, Goncalves Tsumura W, Vaisman M, Montalli Assumpcao LV, and Ward LS: Current recommendations for levothyroxine treatment of differentiated thyroid cancer patients are not properly implemented in a clinical practice. Epub, J Endocrinol Invest 2012.
34. U.S. Institute of Medicine, Panel on Macronutrients, Standing Committee on the Scientific Evaluation of Dietary Reference Intakes: Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids. National Academies Press, Washington, DC, 2005.
35. Diet Win Clínico: Nutrition Evaluation Software. Brubins Comércio de Alimentos e Supergelados, Porto Alegre, Brazil, 2002.
36. Johnson R: Energia. In: Rocca, editor. 10 ed. Mahan KL E-SS, São Paulo, Brazil, 2002.
37. World Health Organization: Diet, Nutrition, and the Prevention of Chronic Diseases. World Health Organization Technical Report Series 797, 1990.
38. World Health Organization: Diet, Nutrition and the Prevention of Chronic Diseases. World Health Organization Technical Report Series 916, 2003.
39. Nascimento S, Barbosa FS, Sichieri R, and Pereira RA: Dietary availability patterns of the Brazilian macro-regions. Nutr J 10 (79), 2011.
40. Guignard R, Truong T, Rougier Y, Baron-Dubourdieu D, and Guenel P: Alcohol drinking, tobacco smoking, and anthropometric characteristics as risk factors for thyroid cancer: a countrywide case-control study in New Caledonia. Am J Epidemiol 166, 1140-1149, 2007.
41. Meinhold CL, Ron E, Schonfeld SJ, Alexander BH, Freedman DM, et al.: Nonradiation risk factors for thyroid cancer in the US Radiologic Technologists Study. Am J Epidemiol 171, 242-252, 2010.
42. Tulinius H, Sigfusson N, Sigvaldason H, Bjarnadottir K, and Tryggvadottir L: Risk factors for malignant diseases: a cohort study on a population of 22,946 Icelanders. Cancer Epidemiol Biomarkers Prev 6, 863-873, 1997.
43. Suzuki T, Matsuo K, Hasegawa Y, Hiraki A, Kawase T, et al.: Anthropometric factors at age 20 years and risk of thyroid cancer. Cancer Causes Control 19, 1233-1242, 2008.
44. Kitahara CM, Platz EA, Freeman LE, Hsing AW, Linet MS, et al.: Obesity and thyroid cancer risk among U.S. men and women: a pooled analysis of five prospective studies. Cancer Epidemiol Biomarkers Prev 20, 464-472, 2011.
45. Ekpechi OL, Dimitriadou A, and Fraser R: Goitrogenic activity of cassava (a staple Nigerian food). Nature 210, 1137-1138, 1966.
46. Ermans AM, Delange F, Van der Velden M, and Kinthaert J: Goitrogenic action of cyanogenic glucosides present in cassava: a possible etiologic factor of endemic goiter in the Idjwi island. Acta Endocrinol Suppl (Copenh) 179 (31), 1973.
47. IBGE: Pesquisa de Orçamentos Familiares 2008-2009: Análise do Consumo Alimentar Pessoal no Brasil. IBGE, Coordenação de Trabalho e Rendimento, Rio de Janeiro, Brazil, 2011.
48. Rezzonico J, Rezzonico M, Pusiol E, Pitoia F, and Niepomniszcze H: High prevalence of thyroid nodules in patients with achrocordons (skin tags). Possible role of insulin-resistance. Medicina (B Aires) 69, 302-304, 2009.
49. Bartholomeusz C and Gonzalez-Angulo AM: Targeting the PI3K signaling pathway in cancer therapy. Expert Opin Ther Targets 16, 121-130, 2012.
50. Nikiforov YE and Nikiforova MN: Molecular genetics and diagnosis of thyroid cancer. Nat Rev Endocrinol 7, 569-580, 2011.
51. Gomez Saez JM: Diagnostic and prognostic markers in differentiated thyroid cancer. Curr Genomics 12, 597-608, 2011.
52. World Health Organization: Diet, nutrition and the prevention of chronic diseases. A report of the WHO Study Group on Diet, Nutrition and Prevention of Noncommunicable Diseases. Nutr Rev 49, 291-301, 1991.
53. Bosetti C, Kolonel L, Negri E, Ron E, Franceschi S, et al.: A pooled analysis of case-control studies of thyroid cancer. VI. Fish and shellfish consumption. Cancer Causes Control 12, 375-382, 2001.
54. Crowe FL, Key TJ, Allen NE, Appleby PN, Roddam A, et al.: The association between diet and serum concentrations of IGF-I, IGFBP-1, IGFBP-2, and IGFBP-3 in the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev 18, 1333-1340, 2009.
55. Key TJ, Appleby PN, Reeves GK, and Roddam AW: Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. Lancet Oncol 11, 530-542, 2010.
56. Roddam AW, Allen NE, Appleby P, Key TJ, Ferrucci L, et al.: Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies. Ann Intern Med 149, 461-471, W83-W8, 2008.
57. Rinaldi S, Cleveland R, Norat T, Biessy C, Rohrmann S, et al.: Serum levels of IGF-I, IGFBP-3 and colorectal cancer risk: results from the EPIC cohort, plus a meta-analysis of prospective studies. Int J Cancer 126, 1702-1715, 2010.
58. Lee SW, Lee SY, Lee SR, Ju W, and Kim SC: Plasma levels of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in women with cervical neoplasia. J Gynecol Oncol 21, 174-180, 2010.